Is ABVC BioPharma, Inc. (ABVC) a Buy, Sell, or Hold?
NASDAQ : ABVC
ABVC BioPharma, Inc.
$1.2 USD
-$0.05 (-4.0%)
- Volume
- 99.58K
- Average Volume
- 137.81K
- Market Capitalization
- $17.39M
- P/E Ratio
- -10.44
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.60
- Year Low
- $0.88
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.12
| Source | Headline |
|---|---|
|
Contrasting ABVC BioPharma (NASDAQ:ABVC) and Edgewise Therapeutics (NASDAQ:EWTX)
ABVC BioPharma (NASDAQ: ABVC - Get Free Report) and Edgewise Therapeutics (NASDAQ: EWTX - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings. Valuation and Earnings This table compares ABVC BioPharma defenseworld.net - 2026-04-27 01:12:46 |
|
ABVC BioPharma (NASDAQ:ABVC) Stock Price Down 3.4% – Time to Sell?
ABVC BioPharma, Inc. (NASDAQ: ABVC - Get Free Report)'s stock price was down 3.4% during trading on Thursday. The stock traded as low as $1.11 and last traded at $1.14. Approximately 49,807 shares changed hands during trading, a decline of 66% from the average daily volume of 146,310 shares. The stock had previously closed at defenseworld.net - 2026-04-24 02:20:53 |
